LB Pharmaceuticals Inc Common Stock

Market Cap

$804M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$28.53+$8.09 (+39.58%)

Jun 5, 2026

52W High $32.8852W Low $14.61

Company Details

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, w...

CEO

—

IPO Date

Sep 11, 2025

Website

lbpharma.us

Key Metrics TTM

Revenue

- YoY

Net Income

-$39M

EPS (Diluted)

Free Cash Flow

-$52M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 13, 2026

PENDING

Q1 2026

May 15, 2026

FY 2025

Mar 26, 2026

Q4 2025

Mar 26, 2026

Q3 2025

Nov 6, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee